HemaSource was founded by dedicated healthcare executives with extensive and diverse backgrounds in medical products, healthcare software, distribution, global markets, logistics, product development, manufacturing and finance.

Tom Jordan

President & Chief Executive Officer

Mr. Jordan is the President and Chief Executive Officer of HemaSource. Prior to joining HemaSource, he spent 11 years with Terumo BCT and most recently held the title of Executive Vice President, Worldwide Commercial Operations. Mr. Jordan also spent 12 years at Baxter International. He has over 25 years of global healthcare experience leading companies in all regions of the world with emphasis in commercial, medical, business development, finance, logistics and product & software development. He has delivered superior business results in many different segments of the global healthcare market including pharmaceuticals, molecular diagnostics, medical devices, medical equipment and software. Mr. Jordan is a graduate of the University of Iowa (BA, Finance) and holds dual citizenship from Germany/United States.

James J. Sielatycki

Executive Vice President, Sales & Marketing

Mr. Sielatycki joined HemaSource in January 2002. His 25 years of diverse experience in the medical field includes operations, sales and marketing. This extensive experience enables him to make significant contributions to HemaSource and its customers. Twelve years of his career were devoted to operations management for the pharmaceutical manufacturing concern, American Biomedical, where he became the company's Vice President of Operations. Mr. Sielatycki also has four years of experience as Marketing Manager with Stryker Surgical and Utah Medical Products as well as five years as Territory Manager selling surgical supplies with DeRoyal Surgical and Cardinal Healthcare.

Christopher Fletcher

Chief Technology Officer

Mr. Fletcher is the CTO of HemaSource. He has 35 years of product development experience. Prior to joining HemaSource, he spent more than 16 years with Terumo BCT where he successfully delivered medical device and software products in therapeutics, cell processing, and automated blood collection. He most recently held the title of Vice President, Global Product Development. In his tenure at Terumo, Mr. Fletcher led the development of a major software system to automate blood center operations. Mr. Fletcher also worked for 17 years at Lockheed Martin. He is an inventor on numerous patents in engineering and software technology. Mr. Fletcher holds BS and MS degrees from the University of Colorado.

Kent F. Janes

Senior Vice President Procurement & Operations

Mr. Janes joined HemaSource in November of 2010. He brings with him 21 years of experience in supply chain management, operations and manufacturing in many industries including automotive, electronics, printing. Mr. Janes began as a buyer of raw components in manufacturing environments and has steadily progressed to the point where he was most recently Director of Operations at Franklin Covey. At Franklin, Mr. Janes was responsible for all printing and packaging operations. Mr. Janes previous work experience in various companies and industries provides him with a broad perspective in areas of supply chain management and operations.

Matt Johnson

Chief Financial Officer and Administration

Mr. Johnson joined HemaSource in 2010 and has deep skills in accounting through both operating and external audit experience. Most recently, Mr. Johnson worked as the Controller of Corporate Finance at C.R. England, Inc., a national trucking company. He also spent over four years working as the Controller of Del Sol, LC, a retail company with over 100 stores throughout the world. Mr. Johnson began his career at Ernst & Young, LLP, where he worked in the audit department, rising to the level of audit manager.

Bryan Potthoff

Senior Vice President, New Market Development

Mr. Potthoff leads the new market development activities for HemaSource, which includes expansion of the US dialysis and blood businesses and establishment of a European operation to serve the needs of the international plasma and dialysis markets. Prior to joining HemaSource, he spent 8 years with Terumo BCT where he most recently served as VP of Business Development and Commercial Finance. Before joining Terumo BCT, Mr. Potthoff spent 25 years structuring customer solutions in the financial services industry including roles leading business units in Europe and North America. Mr. Potthoff holds a BS degree from the University of Colorado and an MBA from the University of Southern California.